(firstQuint)Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin.

 This is a double-blind, two-arm, parallel-group, single-dose study.

 A total of 70 healthy male subjects will be enrolled.

.

 Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin@highlight

This is a double-blind, two-arm, parallel-group, single-dose study.

